Why MSK Direct?
Our unique cancer benefits solution can change the lives of your teams.
Because MSK is 100% focused on cancer, we are positioned to deliver higher survival rates, shorter hospital stays, and less invasive treatment plans for many types of cancer. Our patient-centered care also helps participants proactively manage their health.
MSK Direct provides access to MSK’s cancer expertise that extends far beyond second opinions. Patients can receive online services from MSK experts in collaboration with their treating doctors or in-person services at our regional locations in New York and New Jersey.
The following is a snapshot of our comprehensive features:
Screening, prevention, and early detection
- Customized cancer screening and risk assessment based on personal profile and family history.
- State-of-the-art genetic testing and guidance from MSK counselors on managing inherited cancer risk.
- Direct recommendations on how to interpret or act early on suspicion of cancer for more accurate diagnoses.
- Corporate screening program design for employer or union partners.
Virtual services
- Dedicated interaction across the cancer journey with skilled, experienced Oncology Certified Nurses® (OCNs).
- Assistance with gathering necessary medical records, test results, and biopsy tissue samples.
- Psychosocial support for patients, family members, and/or caregivers throughout the cancer journey.
- Education about the latest relevant clinical trials and resources.*
- Help finding the highest-quality, in-network local hospital using our proprietary National Cancer Care Recommender.
- Review of original pathology slides and radiology test results by MSK specialists and shared with your local, treating physician.*
- Customized cancer care plans created by MSK surgeons and oncologists and shared with your local, treating physician.*
- Video or phone consultation between MSK physician and patient to review and discuss written care plans.*
- Collaborative case review between treating oncologist anywhere in the U.S. and MSK physician.*
- Genetic sequencing and analysis of cancer for quick assessment of proper treatment regimens through MSK’s FDA-approved proprietary technology.**
- Availability to discuss questions and concerns with MSK team at any time during treatment.
*Contact us to learn which services are available where you live.
**If clinically appropriate
In-person services
- Dedicated interaction across the cancer journey with skilled, experienced Oncology Certified Nurses® (OCNs).
- Psychosocial support for patients, family members, and/or caregivers throughout the cancer journey.
- Education about the latest relevant clinical trials and resources.*
- Genetic sequencing and analysis of cancer for quick assessment of proper treatment regimens through MSK’s FDA-approved proprietary technology.**
- Easy scheduling of timely, coordinated, on-site appointments through a dedicated Care Advisor team.
- Assistance with gathering necessary medical records, test results, and biopsy tissue samples.
- Availability to discuss questions and concerns with MSK team at any time during treatment.
*Contact us to learn which services are available where you live.
**If clinically appropriate.
Value-based care
- Collaboration with health insurers to design incentives for optimal patient care and value.
- Alternative payment model setup, such as up-front, fixed pricing for certain types of cancer.
- Designation as an oncology Center of Excellence by health plan administrators who want to boost efficiency and access for employees and union members through a combination of value-based insurance design options, travel support programs, and awareness campaigns for plan participants.
Meet our MSK Direct Leadership Team
Oren Cahlon, MD
Chief Medical Officer, MSK Direct; Deputy Physician-in-Chief for Strategic Partnerships; Vice Chair, Department of Radiation Oncology
Bob T. Li, MD, PhD, MPH
Chief Scientific Officer, MSK Direct; Co-Director, Thoracic Liquid Biopsy Program; Physician Ambassador to China and Asia-Pacific, Bobst International Center
Emily Kauff
General Manager, MSK Direct; Vice President, New Markets
David Henka
Senior Director, MSK Direct Partnerships
Senior Director, Patient Access Programs